Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laya, M. B.
Right arrow Articles by Weinstein, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laya, M. B.
Right arrow Articles by Weinstein, L.

Radiology, Vol 196, 433-437, Copyright © 1995 by Radiological Society of North America


ARTICLES

Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern

MB Laya, JC Gallagher, JS Schreiman, EB Larson, P Watson and L Weinstein
Department of Medicine, University of Washington, Seattle 98195, USA.

PURPOSE: To measure changes and predictors of change in mammograms obtained in postmenopausal women undergoing continuous combined hormonal replacement therapy (HRT). MATERIALS AND METHODS: Mammograms of 41 postmenopausal women obtained before and 1 year after the initiation of HRT were evaluated blindly according to the quantitative density percentage method and the Wolfe classification system. RESULTS: Mammographic densities increased compared with baseline values in 73% of subjects (mean increase, 6.7%; 95% confidence interval, 2.5%, 11.0%; P = .003). A shift in Wolfe classification from lower to greater parenchymal density was noted in 24% of subjects (P = .016). Multivariate analysis results indicated that the lower the tissue density percentage before treatment, the greater the increase in density percentage after treatment. CONCLUSION: An increase in mammographic density was demonstrated in most subjects undergoing continuous combined HRT and was most pronounced in subjects with a lower baseline density percentage.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. B. Terry, D. S.M. Buist, A. Trentham-Dietz, T. M. James-Todd, and Y. Liao
Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1088 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Hwang, D. L. Miglioretti, R. Ballard-Barbash, D. L. Weaver, K. Kerlikowske, and for the National Cancer Institute Breast Cancer Su
Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2587 - 2593.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. E. Martin, M. A. Helvie, C. Zhou, M. A. Roubidoux, J. E. Bailey, C. Paramagul, C. E. Blane, K. A. Klein, S. S. Sonnad, and H.-P. Chan
Mammographic Density Measured with Quantitative Computer-aided Method: Comparison with Radiologists' Estimates and BI-RADS Categories
Radiology, September 1, 2006; 240(3): 656 - 665.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Maskarinec, I. Pagano, G. Lurie, and L. N. Kolonel
A longitudinal investigation of mammographic density: the multiethnic cohort.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. McTiernan, C. F. Martin, J. D. Peck, A. K. Aragaki, R. T. Chlebowski, E. D. Pisano, C. Y. Wang, R. L. Brunner, K. C. Johnson, J. E. Manson, et al.
Estrogen-Plus-Progestin Use and Mammographic Density in Postmenopausal Women: Women's Health Initiative Randomized Trial
J Natl Cancer Inst, September 21, 2005; 97(18): 1366 - 1376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. S. Dite, J. D. Wark, G. G. Giles, D. R. English, M. R.E. McCredie, and J. L. Hopper
Is There Overlap Between the Genetic Determinants of Mammographic Density and Bone Mineral Density?
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2266 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. J. Aiello, S. S. Tworoger, Y. Yasui, F. Z. Stanczyk, J. Potter, C. M. Ulrich, M. Irwin, and A. McTiernan
Associations among Circulating Sex Hormones, Insulin-Like Growth Factor, Lipids, and Mammographic Density in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.-P. Chen, Y.-C. Cheung, L.-F. Teng, and Y.-K. Soong
The relationship between mammographic density and duration of hormone therapy: effects of estrogen and estrogen-progestin
Hum. Reprod., June 1, 2005; 20(6): 1741 - 1745.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
V. M. Barnabei, B. B. Cochrane, A. K. Aragaki, I. Nygaard, R. S. Williams, P. G. McGovern, R. L. Young, E. C. Wells, M. J. O'Sullivan, B. Chen, et al.
Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Women's Health Initiative
Obstet. Gynecol., May 1, 2005; 105(5): 1063 - 1073.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. A. Habel, J. J. Dignam, S. R. Land, M. Salane, A. M. Capra, and T. B. Julian
Mammographic Density and Breast Cancer After Ductal Carcinoma In Situ
J Natl Cancer Inst, October 6, 2004; 96(19): 1467 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. O. Lillie, L. Bernstein, S. A. Ingles, W. J. Gauderman, G. E. Rivas, V. Gagalang, T. Krontiris, and G. Ursin
Polymorphism in the Androgen Receptor and Mammographic Density in Women Taking and Not Taking Estrogen and Progestin Therapy
Cancer Res., February 15, 2004; 64(4): 1237 - 1241.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. A. Harvey and V. E. Bovbjerg
Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk
Radiology, January 1, 2004; 230(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. W. Fletcher and J. G. Elmore
Mammographic Screening for Breast Cancer
N. Engl. J. Med., April 24, 2003; 348(17): 1672 - 1680.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
V. M. Barnabei, D. Grady, D. W. Stovall, J. A. Cauley, F. Lin, C. A. Stuenkel, M. L. Stefanick, and J. H. Pickar
Menopausal Symptoms in Older Women and the Effects of Treatment With Hormone Therapy
Obstet. Gynecol., December 1, 2002; 100(6): 1209 - 1218.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Vachon, T. A. Sellers, R. A. Vierkant, F.-F. Wu, and K. R. Brandt
Case-Control Study of Increased Mammographic Breast Density Response to Hormone Replacement Therapy
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
J. Cheek, J. Lacy, S. Toth-Fejel, K. Morris, K. Calhoun, and R. F. Pommier
The Impact of Hormone Replacement Therapy on the Detection and Stage of Breast Cancer
Arch Surg, September 1, 2002; 137(9): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. J. Messina and C. L. Loprinzi
Soy for Breast Cancer Survivors: A Critical Review of the Literature
J. Nutr., November 1, 2001; 131(11): 3095S - 3108.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
G. Maskarinec, L. Meng, and G. Ursin
Ethnic differences in mammographic densities
Int. J. Epidemiol., October 1, 2001; 30(5): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. M. Rutter, M. T. Mandelson, M. B. Laya, and S. Taplin
Changes in Breast Density Associated With Initiation, Discontinuation, and Continuing Use of Hormone Replacement Therapy
JAMA, January 10, 2001; 285(2): 171 - 176.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Freedman, J. S. Martin, J. O'Gorman, S. Eckert, M. E. Lippman, S.-C. B. Lo, E. L. Walls, and J. Zeng
Digitized Mammography: a Clinical Trial of Postmenopausal Women Randomly Assigned to Receive Raloxifene, Estrogen, or Placebo
J Natl Cancer Inst, January 3, 2001; 93(1): 51 - 56.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. K. Chow, D. Venzon, E. C. Jones, A. Premkumar, J. O’Shaughnessy, and J. Zujewski
Effect of Tamoxifen on Mammographic Density
Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 917 - 921.
[Abstract] [Full Text]


Home page
Int J EpidemiolHome page
E. Sala, R. Warren, J. McCann, S. Duffy, R. Luben, and N. Day
High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study
Int. J. Epidemiol., August 1, 2000; 29(4): 629 - 636.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. T. Mandelson, N. Oestreicher, P. L. Porter, D. White, C. A. Finder, S. H. Taplin, and E. White
Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
J Natl Cancer Inst, July 5, 2000; 92(13): 1081 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Atkinson, R. Warren, S. A. Bingham, and N. E. Day
Mammographic Patterns as a Predictive Biomarker of Breast Cancer Risk: Effect of Tamoxifen
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 863 - 866.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
C. J. Baines and R. Dayan
A Tangled Web: Factors Likely to Affect the Efficacy of Screening Mammography
J Natl Cancer Inst, May 19, 1999; 91(10): 833 - 838.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. A. Greendale, B. A. Reboussin, A. Sie, H. R. Singh, L. K. Olson, O. Gatewood, L. W. Bassett, C. Wasilauskas, T. Bush, E. Barrett-Connor, et al.
Effects of Estrogen and Estrogen-Progestin on Mammographic Parenchymal Density
Ann Intern Med, February 16, 1999; 130(4_Part_1): 262 - 268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1995 by the Radiological Society of North America.